V-CREATE and VACS's work looking at individuals with HIV infection and their heart failure outcomes was recently featured in research news @ Vanderbilt. This is the first large study to reveal a higher risk of heart failure with reduced and preserved ejection fraction in HIV-infected individuals. The research news article highlights Dr. Freiberg's views regarding the implications of improved HIV treatment in the context of heart disease. The study was published in JAMA Cardiology.
